Neurotropic viruses are well-established causes of direct viral encephalitis. Emerging evidence reveals that many CNS complications following these infections are immune-mediated rather than virally driven. Guillain-Barré syndrome(GBS), acute disseminated encephalomyelitis(ADEM), and autoimmune encephalitis(AE) have been increasingly recognized in association with viral infections. Understanding these syndromes is critical for differentiating post-infectious immune phenomena from active viral disease, guiding appropriate further immunotherapy versus antiviral therapy.

We identified a convergent pattern of post-infectious, antibody-mediated neuroinflammation across multiple neurotropic viruses.

For HSV, immune-mediated relapses (anti-NMDAR autoimmune encephalitis) were reported in ~10–25% of patients recovering from HSV-1 encephalitis, typically emerging 2–12 weeks after the acute illness.

CMV is implicated in GBS and immune-reconstitution syndromes, particularly in immunocompromised recipients.

Zika virus shows the most robust epidemiologic link to GBS and ADEM: published outbreak analyses and modeling estimated ~0.2–2.4 GBS cases/10,000 Zika infections, and multiple case-control studies have detected anti-ganglioside antibodies more often in Zika-associated GBS patients than in infected controls, supporting molecular-mimicry–driven axonal injury.

Rabies-associated autoimmune-like syndromes remain rare and are principally reported after vaccination or abortive infections in isolated case reports; quantitative incidence data are lacking.

Immune-mediated neurological syndromes represent an under-recognized, clinically significant spectrum of post-viral complications. Differentiating them from direct viral encephalitis is essential for timely IVIG, plasmapheresis, or corticosteroids. Syndrome recognition enhances diagnostic accuracy, improves patient outcomes, and informs future research on neuro-immune interactions and vaccine safety.